Morgan Stanley
GEVA

Morgan Stanley’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Morgan Stanley’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$1.54M Sell
2014
Q4 		$1.49M Sell
2014
Q3 		$1.58M Sell
2014
Q2 		$2.92M Buy
2014
Q1 		$922K Sell
2013
Q4 		$2.03M Buy
2013
Q3 		$1.03M Sell
2013
Q2 		$1.01M Buy